Overview

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Status:
Completed
Trial end date:
2011-11-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether AN2898 and AN2728 ointments are safe and effective treatments for mild-to-moderate atopic dermatitis (AD).
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer